Nanobiotix (NBTX) Revenue: 2020-2024

  • Nanobiotix's Revenue rose 80.48% to $1.2 million in Q2 2024 from the same period last year, while for Jun 2024 it was $210,603, marking a year-over-year increase of 111.19%. This contributed to the annual value of $12.4 million for FY2024, which is 61.85% down from last year.
  • Nanobiotix's Revenue amounted to $1.2 million in Q2 2024, which was up 201.20% from -$1.2 million recorded in Q4 2023.
  • Nanobiotix's 5-year Revenue high stood at $1.2 million for Q2 2024, and its period low was -$1.6 million during Q2 2021.
  • Over the past 3 years, Nanobiotix's median Revenue value was $98,327 (recorded in 2022), while the average stood at $52,651.
  • Data for Nanobiotix's Revenue shows a peak YoY skyrocketed of 243.06% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Nanobiotix's Revenue stood at -$541,300 in 2020, then increased by 9.55% to -$489,620 in 2021, then soared by 71.25% to -$456,700 in 2022, then skyrocketed by 243.06% to -$1.2 million in 2023, then surged by 80.48% to $1.2 million in 2024.
  • Its Revenue was $1.2 million in Q2 2024, compared to -$1.2 million in Q4 2023 and $653,355 in Q2 2023.